Antibody-based drug could hinder progression.
No matter how far-reaching a viral epidemic is, some people don't become infected when exposed to the virus, and this may be due to their innate immunity. Researchers who are studying how and why this happens are paving the way for the creation of an antibody-based medication that will prevent or slow the progression of HIV to AIDS.
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018450:Disease Progression; D015696:Gene Products, tat / Q000276:immunology; D015658:HIV Infections / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008212:Lymphocyte Depletion; D054322:tat Gene Products, Human Immunodeficiency Virus
D000911:Antibodies, Monoclonal; D015696:Gene Products, tat; D054322:tat Gene Products, Human Immunodeficiency Virus